107 related articles for article (PubMed ID: 38873474)
1. Effect of the combined intervention of low-FODMAPs diet and probiotics on IBS symptoms in Western China: A randomized controlled trial.
Liu Y; Jin D; He T; Liao X; Shao L; Shi L; Liu L
Food Sci Nutr; 2024 Jun; 12(6):3993-4004. PubMed ID: 38873474
[TBL] [Abstract][Full Text] [Related]
2. Long-Term Effects of a Web-Based Low-FODMAP Diet Versus Probiotic Treatment for Irritable Bowel Syndrome, Including Shotgun Analyses of Microbiota: Randomized, Double-Crossover Clinical Trial.
Ankersen DV; Weimers P; Bennedsen M; Haaber AB; Fjordside EL; Beber ME; Lieven C; Saboori S; Vad N; Rannem T; Marker D; Paridaens K; Frahm S; Jensen L; Rosager Hansen M; Burisch J; Munkholm P
J Med Internet Res; 2021 Dec; 23(12):e30291. PubMed ID: 34904950
[TBL] [Abstract][Full Text] [Related]
3. A Diet Low in FODMAPs Reduces Symptoms in Patients With Irritable Bowel Syndrome and A Probiotic Restores Bifidobacterium Species: A Randomized Controlled Trial.
Staudacher HM; Lomer MCE; Farquharson FM; Louis P; Fava F; Franciosi E; Scholz M; Tuohy KM; Lindsay JO; Irving PM; Whelan K
Gastroenterology; 2017 Oct; 153(4):936-947. PubMed ID: 28625832
[TBL] [Abstract][Full Text] [Related]
4. A diet low in FODMAPs reduces symptoms of irritable bowel syndrome.
Halmos EP; Power VA; Shepherd SJ; Gibson PR; Muir JG
Gastroenterology; 2014 Jan; 146(1):67-75.e5. PubMed ID: 24076059
[TBL] [Abstract][Full Text] [Related]
5. Long-term irritable bowel syndrome symptom control with reintroduction of selected FODMAPs.
Harvie RM; Chisholm AW; Bisanz JE; Burton JP; Herbison P; Schultz K; Schultz M
World J Gastroenterol; 2017 Jul; 23(25):4632-4643. PubMed ID: 28740352
[TBL] [Abstract][Full Text] [Related]
6. Diet low in FODMAPs reduces symptoms of irritable bowel syndrome as well as traditional dietary advice: a randomized controlled trial.
Böhn L; Störsrud S; Liljebo T; Collin L; Lindfors P; Törnblom H; Simrén M
Gastroenterology; 2015 Nov; 149(6):1399-1407.e2. PubMed ID: 26255043
[TBL] [Abstract][Full Text] [Related]
7. Fermentable oligo-, di-, monosaccharides, and polyols (FODMAPs), but not gluten, elicit modest symptoms of irritable bowel syndrome: a double-blind, placebo-controlled, randomized three-way crossover trial.
Nordin E; Brunius C; Landberg R; Hellström PM
Am J Clin Nutr; 2022 Feb; 115(2):344-352. PubMed ID: 34617561
[TBL] [Abstract][Full Text] [Related]
8. Effects of FODMAPs and Gluten on Gut Microbiota and Their Association with the Metabolome in Irritable Bowel Syndrome: A Double-Blind, Randomized, Cross-Over Intervention Study.
Nordin E; Hellström PM; Dicksved J; Pelve E; Landberg R; Brunius C
Nutrients; 2023 Jul; 15(13):. PubMed ID: 37447371
[TBL] [Abstract][Full Text] [Related]
9. Low FODMAP diet reduces gastrointestinal symptoms in irritable bowel syndrome and clinical response could be predicted by symptom severity: A randomized crossover trial.
Algera JP; Demir D; Törnblom H; Nybacka S; Simrén M; Störsrud S
Clin Nutr; 2022 Dec; 41(12):2792-2800. PubMed ID: 36384081
[TBL] [Abstract][Full Text] [Related]
10. Clinical effectiveness of adding probiotics to a low FODMAP diet: Randomized double-blind placebo-controlled study.
Turan B; Bengi G; Cehreli R; Akpınar H; Soytürk M
World J Clin Cases; 2021 Sep; 9(25):7417-7432. PubMed ID: 34616808
[TBL] [Abstract][Full Text] [Related]
11. Multivariate modelling of faecal bacterial profiles of patients with IBS predicts responsiveness to a diet low in FODMAPs.
Bennet SMP; Böhn L; Störsrud S; Liljebo T; Collin L; Lindfors P; Törnblom H; Öhman L; Simrén M
Gut; 2018 May; 67(5):872-881. PubMed ID: 28416515
[TBL] [Abstract][Full Text] [Related]
12. A Comparison of the Low-FODMAPs Diet and a Tritordeum-Based Diet on the Gastrointestinal Symptom Profile of Patients Suffering from Irritable Bowel Syndrome-Diarrhea Variant (IBS-D): A Randomized Controlled Trial.
Russo F; Riezzo G; Orlando A; Linsalata M; D'Attoma B; Prospero L; Ignazzi A; Giannelli G
Nutrients; 2022 Apr; 14(8):. PubMed ID: 35458106
[TBL] [Abstract][Full Text] [Related]
13. A low FODMAP diet plus traditional dietary advice versus a low-carbohydrate diet versus pharmacological treatment in irritable bowel syndrome (CARIBS): a single-centre, single-blind, randomised controlled trial.
Nybacka S; Törnblom H; Josefsson A; Hreinsson JP; Böhn L; Frändemark Å; Weznaver C; Störsrud S; Simrén M
Lancet Gastroenterol Hepatol; 2024 Jun; 9(6):507-520. PubMed ID: 38643782
[TBL] [Abstract][Full Text] [Related]
14. Influence of low FODMAP-gluten free diet on gut microbiota alterations and symptom severity in Iranian patients with irritable bowel syndrome.
Naseri K; Dabiri H; Rostami-Nejad M; Yadegar A; Houri H; Olfatifar M; Sadeghi A; Saadati S; Ciacci C; Iovino P; Zali MR
BMC Gastroenterol; 2021 Jul; 21(1):292. PubMed ID: 34261437
[TBL] [Abstract][Full Text] [Related]
15. A randomized double-blind, placebo-controlled trial to evaluate the safety and efficacy of live
Srivastava S; Basak U; Naghibi M; Vijayakumar V; Parihar R; Patel J; Jadon PS; Pandit A; Dargad RR; Khanna S; Kumar S; Day R
Gut Microbes; 2024; 16(1):2338322. PubMed ID: 38630015
[TBL] [Abstract][Full Text] [Related]
16. FODMAPs alter symptoms and the metabolome of patients with IBS: a randomised controlled trial.
McIntosh K; Reed DE; Schneider T; Dang F; Keshteli AH; De Palma G; Madsen K; Bercik P; Vanner S
Gut; 2017 Jul; 66(7):1241-1251. PubMed ID: 26976734
[TBL] [Abstract][Full Text] [Related]
17. Is Bacillus coagulans supplementation plus low FODMAP diet superior to low FODMAP diet in irritable bowel syndrome management?
Abhari K; Saadati S; Hosseini-Oskouiee F; Yari Z; Hosseini H; Sohrab G; Hejazi E; Agah S; Sadeghi A; Hekmatdoost A
Eur J Nutr; 2020 Aug; 59(5):2111-2117. PubMed ID: 31327047
[TBL] [Abstract][Full Text] [Related]
18. Evaluation of the effects of the FODMAP diet and probiotics on irritable bowel syndrome (IBS) symptoms, quality of life and depression in women with IBS.
Ustaoğlu T; Tek NA; Yıldırım AE
J Hum Nutr Diet; 2024 Feb; 37(1):5-17. PubMed ID: 37430435
[TBL] [Abstract][Full Text] [Related]
19. IBS randomized study: FODMAPs alter bile acids, phenolic- and tryptophan metabolites, while gluten modifies lipids.
Nordin E; Hellström PM; Vuong E; Ribbenstedt A; Brunius C; Landberg R
Am J Physiol Regul Integr Comp Physiol; 2023 Sep; 325(3):R248-R259. PubMed ID: 37399002
[TBL] [Abstract][Full Text] [Related]
20. Effects of varying dietary content of fermentable short-chain carbohydrates on symptoms, fecal microenvironment, and cytokine profiles in patients with irritable bowel syndrome.
Hustoft TN; Hausken T; Ystad SO; Valeur J; Brokstad K; Hatlebakk JG; Lied GA
Neurogastroenterol Motil; 2017 Apr; 29(4):. PubMed ID: 27747984
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
